Physician profile
James E Ridge
NPI 1811004690
$2,201.17
in general payments reported to CMS, 2019-2025
20 companies · $707 in 2025
The $707 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.73 · 2021: $80.46 · 2022: $834 · 2023: $252 · 2024: $279 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $518.80 | 2022 | |
| Abbvie INC. | $467.62 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $334.54 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $187.48 | 2020-2025 | Rocklatan, Eysuvis, Tryptyr |
| Sight Sciences, INC. | $94.49 | 2025 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $83.74 | 2020-2025 | |
| Biotissue Holdings INC. | $74.39 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $66.98 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $56.08 | 2022-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $47.59 | 2022 | |
| Harrow Eye, LLC | $46.61 | 2024 | Triesence, Iheezo |
| Oyster Point Pharma, INC. | $40.37 | 2022 | |
| Allergan, INC. | $38.02 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $34.75 | 2025 | Syfovre |
| Aerie Pharmaceuticals, INC. | $20.17 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $19.50 | 2020 | |
| Dompe US, INC. | $19.04 | 2024 | Oxervate |
| Thea Pharma INC. | $18.78 | 2025 | Iyuzeh |
| Horizon Therapeutics Plc | $16.54 | 2022 | |
| Coopervision INC. | $15.68 | 2023 | Myday Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.